Skip to content

PHARM.ASSY: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARM.ASSY

BE 0689.606.850
NACE 47.730, Retail sale of pharmaceutical products
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€25,201
2024 · €26,002-€801
Equity
€149,646
2024 · €124,952+€24,694
Cash
€47,416
2024 · €45,317+€2,099
Balance sheet total
€268,957
2024 · €242,082+€26,875

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€44,723

    up €44,723 (+404.8%), from €11,049 to €55,772

    of which Other tangible fixed assets: +€49,375

  • Intangible fixed assets -€18,000

    down €18,000 (-30.8%), from €58,500 to €40,500

  • Receivables within one year -€4,065

    down €4,065 (-10.4%), from €39,158 to €35,093

    of which Trade receivables: -€2,371

Equity and liabilities
  • Debts after one year -€25,347

    down €25,347 (-48.0%), from €52,792 to €27,445

  • Reserves +€20,000

    up €20,000 (+1078.2%), from €1,855 to €21,855

    of which Distributable reserves: +€20,000

  • Tax, wage and social debts +€17,064

    up €17,064 (+112.5%), from €15,161 to €32,225

    of which Taxes: +€14,519

  • Trade debts +€10,188

    up €10,188 (+50.8%), from €20,070 to €30,258

  • Profit (loss) carried forward +€4,694

    up €4,694 (+4.5%), from €104,547 to €109,241

Income statement
  • Turnover -€646,533

    no longer reported in 2025 (was €646,533)

  • Purchases and services -€550,386

    no longer reported in 2025 (was €550,386)

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €26,002
Gross operating margin +€4,945
Staff costs -€1,079
Depreciation -€1,862
Other operating charges -€382
Financial income -€759
Financial charges +€2,304
Taxes -€3,969
Result 2025 €25,201

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€84,002
Investment -€54,921
Financing -€26,981
Cash 2024 €45,317
Net result for the year +€25,201
Depreciation +€28,198
Stocks and contracts -€2,118
Receivables within one year +€4,065
Trade debts +€10,188
Tax, wage and social debts +€17,064
Other debts +€1,403
Investment in fixed assets (net) -€54,921
Debts after one year -€25,347
Current portion of long-term debt -€1,126
Contributions, distributions and other -€508
Cash 2025 €47,416
Every line side by side 52 lines
Line Code 2024 2025 Change %
Total assets 20/58 €242,082 €268,957 +€26,875 +11.1%
Fixed assets 21/28 €70,914 €97,637 +€26,723 +37.7%
Intangible fixed assets 21 €58,500 €40,500 -€18,000 -30.8%
Tangible fixed assets 22/27 €11,049 €55,772 +€44,723 +404.8%
Plant, machinery and equipment 23 €796 €0 -€796 -100.0%
Furniture and vehicles 24 €10,253 €6,397 -€3,857 -37.6%
Other tangible fixed assets 26 - €49,375 +€49,375
Financial fixed assets 28 €1,365 €1,365 = 0.0%
Current assets 29/58 €171,168 €171,320 +€152 +0.1%
Stocks and contracts in progress 3 €86,693 €88,811 +€2,118 +2.4%
Stocks 30/36 €86,693 €88,811 +€2,118 +2.4%
Amounts receivable within one year 40/41 €39,158 €35,093 -€4,065 -10.4%
Trade receivables 40 €37,442 €35,071 -€2,371 -6.3%
Other amounts receivable 41 €1,716 €21 -€1,694 -98.8%
Cash at bank and in hand 54/58 €45,317 €47,416 +€2,099 +4.6%
Total equity and liabilities 10/49 €242,082 €268,957 +€26,875 +11.1%
Equity 10/15 €124,952 €149,646 +€24,694 +19.8%
Contributions 10/11 €18,550 €18,550 = 0.0%
Capital 10 €18,550 - -€18,550
Issued capital 100 €18,550 - -€18,550
Reserves 13 €1,855 €21,855 +€20,000 +1078.2%
Non-distributable reserves 130/1 €1,855 €1,855 = 0.0%
Legal reserve 130 €1,855 - -€1,855
Reserves not available under the articles 1311 - €1,855 +€1,855
Distributable reserves 133 - €20,000 +€20,000
Profit (loss) carried forward 14 €104,547 €109,241 +€4,694 +4.5%
Amounts payable 17/49 €117,130 €119,311 +€2,181 +1.9%
Amounts payable after more than one year 17 €52,792 €27,445 -€25,347 -48.0%
Financial debts 170/4 €52,792 €27,445 -€25,347 -48.0%
Amounts payable within one year 42/48 €64,338 €91,866 +€27,528 +42.8%
Current portion of amounts payable after more than one year 42 €26,474 €25,347 -€1,126 -4.3%
Trade debts 44 €20,070 €30,258 +€10,188 +50.8%
Suppliers 440/4 €20,070 €30,258 +€10,188 +50.8%
Taxes, remuneration and social security 45 €15,161 €32,225 +€17,064 +112.5%
Taxes 450/3 €10,257 €24,776 +€14,519 +141.6%
Remuneration and social security 454/9 €4,904 €7,449 +€2,544 +51.9%
Other amounts payable 47/48 €2,633 €4,036 +€1,403 +53.3%
Turnover 70 €646,533 - -€646,533
Goods, raw materials, services and sundry goods 60/61 €550,386 - -€550,386
Remuneration, social security and pensions 62 €31,043 €32,122 +€1,079 +3.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €26,336 €28,198 +€1,862 +7.1%
Other operating charges 640/8 €660 €1,042 +€382 +57.9%
Gross operating margin 9900 €96,147 €101,093 +€4,945 +5.1%
Operating profit (loss) 9901 €38,108 €39,730 +€1,622 +4.3%
Financial income 75/76B €3,662 €2,903 -€759 -20.7%
Recurring financial income 75 €3,662 €2,903 -€759 -20.7%
Financial charges 65/66B €5,255 €2,951 -€2,304 -43.9%
Recurring financial charges 65 €5,255 €2,951 -€2,304 -43.9%
Profit (loss) for the period before taxes 9903 €36,515 €39,683 +€3,168 +8.7%
Income taxes 67/77 €10,513 €14,482 +€3,969 +37.8%
Profit (loss) for the period 9904 €26,002 €25,201 -€801 -3.1%
Profit (loss) for the period to be appropriated 9905 €26,002 €25,201 -€801 -3.1%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.